Enzyme-linked immunosorbent assay and agar gel immunodiffusion assay for diagnosis of equine infectious anemia employing p26 protein fused to the maltose-binding protein
A codon-optimized equine infectious anemia virus p26 gene was fused to a maltose-binding protein (MBP) and expressed in Escherichia coli for use as an antigen in agar gel immunodiffusion (AGID) and enzyme-linked immunosorbent assay (ELISA) for diagnosis of equine infectious anemia. An analysis of analytical sensitivity and specificity showed that the antigen MBP-p26rec reacted positively with a reference World Organization for Animal Health serum and demonstrated no cross-reaction against sera from vaccinated animals in either test. The diagnostic characteristics were evaluated and presented excellent values. The AGIDrec showed 100% sensitivity and specificity, and the ELISArec showed 100% sensitivity and 99.64% specificity. In addition, MBP-p26rec was stabile after three years of storage at 4 °C, maintaining its immunoreactivity.
This work was funded by the Foundation for Science and Technology Support of the State of Pernambuco (FACEPE), the Financier of Studies and Projects (FINEP), and Biovetech (PAPPE - 2008; Proc APS 0338-5.05/08). Scholarships were awarded by the Brazilian agencies CAPES and CNPq. The authors are grateful to Dr. Hans Aymeric from Equine Diseases Laboratory (Maisons-Alfort, France) for kindly providing the OIE anti-EIAV reference serum, and to the Brazilian Ministry of Agriculture, Livestock and Supply for permission to import the serum.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
All authors have seen and agree with the contents of the manuscript.
- 5.World Organization for Animal Health (OIE) (2017) http://www.oie.int/animal-health-in-the-world/oie-listed-diseases-2017/. Acesso em: 14 Aug 2017
- 6.Montelaro RC, Parekh B, Orrego A, Issel CJ (1984) Antigenic variation during persistent infection by equine infectious anaemia, a retrovirus. J Biol Chem 16:10539–10544Google Scholar
- 9.Piza AST, Perira AR, Terreran MT, Mozzer O, Tanuri A, Brandão PE, Richtzenhain LJ (2007) Serodiagnosis of equine infectious anemia by agar gel immunodiffusion and ELISA using a recombinant p26 viral protein expressed in Escherichia coli as antigen. Prev Vet Med 78:239–245CrossRefPubMedGoogle Scholar
- 10.Kong XK, Pang H, Sugiura T, Sentsui H, Onodera T, Matsumoto Y, Akashi H (1997) Application of equine infectious anaemia virus core proteins produced in a Baculovirus expression system, to serological diagnosis. MicrobiolImmunol 41:975–980Google Scholar
- 13.Walper SA, Battle SR, Lee PAB, Zabetakis D, Turner KB, Buckley PE, Calm AM, Welsh HS, Warner CR, Zacharko MA, Goldman ER, Anderson GP (2014) Thermostable single domain antibody-maltose binding protein fusion for Bacillus anthracis spore protein BclA detection. Anal Biochem 447:64–73CrossRefPubMedGoogle Scholar
- 17.Singha H, Goyal SK, Malik P, Khurana SK, Raj K, Singh RK (2013) Development, evaluation, and laboratory validation of immunoassays for the diagnosis of equine infectious anemia (EIA) using recombinant protein produced from a synthetic p26 gene of EIA virus. Indian J Virol 24(3):349–356CrossRefPubMedPubMedCentralGoogle Scholar
- 19.Metz CE (1978) Basic principles of ROC analysis. SeminNucl Med 8(4):283–298Google Scholar
- 23.Banoo S, Bell D, Bossuyt P, Herring A, Mabey D, Poole F, Smith PG, Sriram N, Wongsrichanalai C, Linke R, O’brien R, Perkins M, Cunningham J, Matsoso P, Nathanson CM, Olliaro P, Peeling RW, Ramsay A (2010) Evaluation of diagnostic tests for infectious diseases: general principles. The TDR diagnostic evaluation panel. Nat Rev Microbiol 4:S21–S31Google Scholar
- 24.Reis JKP, Rejane S, Diniz RS, Haddad JPA, Ferraz IBF, Alex F, Carvalho AF, Kroon EG, Ferreira PCP, Leite RC (2012) Recombinant envelope protein (rgp90) ELISA for equine infectious anemia virus provides comparable results to the agar gel immunodiffusion. J Virol Methods 180:62–67CrossRefPubMedGoogle Scholar